ArticleFrontiers in immunology2020

ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma.

Michael Merker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.